Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca pays $50 million for rights to Merck cancer drug
AstraZeneca pays $50 million for rights to Merck cancer drug
AstraZeneca pays $50 million for rights to Merck cancer drug
Submitted by
admin
on September 11, 2013 - 8:50am
Source:
Yahoo/Reuters
News Tags:
Merck
AstraZeneca
ovarian cancer
MK-1775
Headline:
AstraZeneca pays $50 million for rights to Merck cancer drug
Do Not Allow Advertisers to Use My Personal information
